Single Use Support - Cold Chain

EDITORIAL SECTION

  • STRATEGY

    Smarter Pharma

    Quality management systems QMS are the backbone of pharmaceutical manufacturing ensuring safe products

KNOWLEDGE BANK

  • Articles

    Revolutionizing Healthcare with Innovative Therapeutics

    Revolutionizing healthcare with innovative therapeutics involves the development and application of groundbreaking treatments and approaches that significantly improve patient outcomes reduce costs and enhance overall healthcare effectiveness

    Personalized Medicine and Longevity: Advancing the Frontier

    The world is experiencing a profound demographic shift with population aging impacting healthcare economies and human rights The United Nations projects that by the number of people aged and over will double to billion comprising one in six people worldwide United Nations OHCHR By older adults will likely outnumber children necessitating a rethink of health aging and longevity Hartmann Young

    What Are the Benefits of Implementing a Modern MES in Pharma?

    The pharmaceutical sector is rapidly changing in a bid to match the increasing pressure of regulation attain perfection in product quality and hasten the timetomarket A Pharma MES or Manufacturing Execution System is one of the most strategic investments that are strategically placed in this environment in terms of operational excellence

    Biopharmaceutical Facility Design for Sustainability: A Comprehensive Overview

    The design and operation of biopharmaceutical facilities play a pivotal role in shaping the environmental impact of the pharmaceutical industry In recent years there has been a growing emphasis on sustainability within this sector

    Data Security Challenges in Pharma IT: Safeguarding Sensitive Information

    The pharmaceutical industry faces several data security challenges in its IT infrastructure primarily related to safeguarding sensitive information The nature of the data regulatory requirements and the increasing sophistication of cyber threats

    The Competitive Generic Therapy (CGT)

    Generic medications are critical in the healthcare sector due to their affordability and accessibility to the public while maintaining comparable quality efficacy and safety to that of branded products Generic medications research and development followed by commercialisation also fosters competition and innovation within the pharmaceutical

TOP ARTICLES

  • 5

    The Competitive Generic Therapy (CGT)

    Raghunandhan Painoori

    Dr. Naveen Chella

    The Competitive Generic Therapy (CGT) Act, introduced by the US FDA in 2017 under the Generic Drug User Fee Act (GDUFA), aims to lower drug costs by promoting generics where competition is limited. It...

press releases Read more...

FDA accepts New Drug Application for Roche’s giredestrant in ER-positive early-stage breast cancer, the first and only oral SERD with positive phase III results in the curative setting

Roche announced today that the United States US Food and Drug Administration FDA has accepted the companys New Drug Application NDA under Priority Review for giredestrant an investigational oral selective

Decoy Therapeutics Partners with hVIVO to Advance Lead D-MAV™ Candidate into the Clinic

Decoy Therapeutics Inc a preclinicalstage biotechnology company pioneering a new category of antivirals today announced the execution of a strategic development initiative designed to support

Sino Biological’s Cell-Free Protein Synthesis Supports Tencent AI for Life Sciences Lab’s Protein Design Study Published in Nature Communications

Sino Biological Inc Shenzhen Stock Exchange SZ has announced that its gene synthesis and cellfree protein expression workflow was used in a recent study by Tencent AI for Life Sciences Lab published in Nature

T-CURX Acquires Pantherna Therapeutics to Accelerate Clinical Translation of its Non-Viral In Vivo CAR-T Strategies

Leading CART company TCURX announces the signing of a definitive agreement for the acquisition of Pantherna Therapeutics a German biotechnology company specializing in mRNA engineering and lipid nanoparticle LNP

01 - 02

Jun 2026

Future Pharma 2026

Renaissance Seaport District, Boston, MA, USA

02 - 04

Jun 2026

CPHI Americas 2026

Pennsylvania Convention Center, Philadelphia, USA

04 - 05

Jun 2026

Pharmac South 2026

Chennai Trade Centre, Nandambakkam, India

04 - 06

Jun 2026

09 - 11

Jun 2026

5th World ADC Summit South Korea

COEX Magok Lewest, 143 Magokjungang-ro, Gangseo-gu, Seoul, South Korea

09 - 11

Jun 2026

World TPD & Induced Proximity Summit South Korea

COEX Magok Lewest, 143 Magokjungang-ro, Gangseo-gu, Seoul, South Korea

09 - 11

Jun 2026

World Targeted Therapeutics Summit South Korea

COEX Magok Lewest, 143 Magokjungang-ro, Gangseo-gu, Seoul, South Korea

09 - 10

Jun 2026

ChemE Show 2026

George R. Brown Convention Center, Houston, Texas, USA

LATEST NEWS Read more...

Haisco and Lilly Enter Research and Licensing Partnership for Innovative Medicines

Haisco Pharmaceutical Group Co Ltd has entered into a licensing and research collaboration with Eli Lilly and Company to develop innovative medicines across multiple therapeutic areas

Vertex Receives FDA Acceptance for Povetacicept Application in IgA Nephropathy

Vertex Pharmaceuticals has announced that the US Food and Drug Administration FDA has accepted its Biologics License Application BLA for povetacicept an investigational treatment for adults with immunoglobulin A nephropathy IgAN

FDA Grants Breakthrough Therapy Status to Merck’s Calderasib for KRAS G12C-Mutated NSCLC

Merck known as MSD outside the United States and Canada has received Breakthrough Therapy designation from the US Food and Drug Administration FDA for calderasib MK an investigational oral KRAS GC inhibitor

Innovent Biologics and Pfizer form global partnership for oncology drug development

Innovent Biologics and Pfizer have entered into a global strategic collaboration to develop earlystage and newly discovered cancer medicines The agreement covers the research and development of antibodydrug conjugates

Alzprotect receives FDA clearance for AZP2006 trial in PSP

Alzprotect has received clearance from the US Food and Drug Administration for its Investigational New Drug IND application for AZP Ezeprogind to treat Progressive Supranuclear Palsy PSP

CordenPharma to Acquire AmbioPharm to Expand Global Peptide API Capacity

CordenPharma has announced an agreement to acquire AmbioPharm a USbased peptide active pharmaceutical ingredient API contract development and manufacturing organisation CDMO